Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hardman & Co call the lithium market: is a change in trend happening?
Tower Resources identify 18 million barrels of contingent reserves worth $118M in Cameroon


Tau Capital Share Price (TAU)



Share Price Information for Tau Capital (TAU)


Share Price: 0.0225Bid: 0.015Ask: 0.03Change: 0.00 (0.00%)No Movement on Tau Capital
Spread: 0.015Spread as %: 100.00%Open: 0.0225High: 0.0225Low: 0.0225Yesterday’s Close: 0.0225

Tau Capital Plc Ord 1P

Tau Capital is part of the Financials sector






Share Price SpacerPrice
0.0225
Share Price SpacerBid
0.015
Share Price SpacerAsk
0.03
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
0.0225
Share Price SpacerHigh
0.0225
Share Price SpacerLow
0.0225
Share Price SpacerClose
0.0225
Share Price SpacerCurrency
USD


Currency Issue Country Shares in Issue Market Capitalisation Market Size
USD JE 48.98m $1 Million 10,000

52 Week High 0.06 52 Week High Date 23-MAR-2018
52 Week Low 0.02 52 Week Low Date 5-OCT-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -0.205 -0.11 0.00 0.00


London South East Users info for Tau Capital




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

31-Oct-18
15:50:58
0.0006
798,614
Sell* 
0.015
0.03
479.17
Trade Type:
Ordinary
Delayed publication

31-Oct-18
15:50:58
0.0006
-798,614
Sell* 
0.015
0.03
-479.17
Trade Type:
Ordinary
Deletion
Delayed publication

31-Oct-18
15:50:58
0.0006
798,614
Sell* 
0.015
0.03
479.17
Trade Type:
Ordinary




View more Tau Capital trades >>

Directors Deals for Tau Capital (TAU)
Trade DateActionNotifierPriceCurrencyAmountHolding
14-May-13Sell
Trade Notifier Information for Tau Capital
Richard Horlick held the position of Non-Executive Director at Tau Capital at the time of this trade.
 Richard Horlick
0.34USD2,898,0000
31-Dec-10Notification of Holding
Trade Notifier Information for Tau Capital
Richard Horlick held the position of Non-Executive Director at Tau Capital at the time of this trade.
 Richard Horlick
0022600000
31-Dec-10Notification of Holding
Trade Notifier Information for Tau Capital
Philip Lambert held the position of Non-Executive Chairman at Tau Capital at the time of this trade.
 Philip Lambert
000
View more Tau Capital directors dealings >>


rjmahan
Posts: 41
Opinion:No Opinion
Price:0.0375
Stolpharm giveaway
28 Aug '18
Think everyone should vote no to sale resolution - Stolpharm is worth more.
hTTps://deepvalueinvestments.wordpress.com/2018/08/28/tau-vote-no-on-giveaway-sale/#more-2113
draft
Posts: 14,996
Opinion:No Opinion
Price:0.0375
just stinks
26 Jun '18
impairment out of the blue. all indicators were it was going well
draft
Posts: 14,996
Opinion:No Opinion
Price:65.525
valuation uplift
24 Jun '18
im expecting a uplift
draft
Posts: 14,996
Opinion:No Opinion
Price:0.0575
website updated
12 Jun '18
more vacancies and promotions and new look team profiles.

expecting a big update here. plus new TR1 holder
draft
Posts: 14,996
Opinion:No Opinion
Price:0.0575
https://astanatimes.com/2018/03/kaz
13 May '18
https://astanatimes.com/2018/03/kazakh-domestic-pharmaceutical-production-up-79-8-percent-in-2017/

Kazakh domestic pharmaceutical production up 79.8 percent in 2017

By Yerbolat Uatkhanov in Business on 2 March 2018

ASTANA � The Kazakh pharmaceutical industry increased production of the country�s most popular medications by 73.1 percent with production increasing 79.8 percent over 2016. Prices for pharmaceutical products in Kazakhstan have also increased 6.6 percent over the last 12 months.The production increases are an attempt by the Kazakh pharmaceutical industry to replace imports with domestic production.

Among the high production areas were the Almaty region (52.8 percent of total domestic production), the South Kazakhstan region (18.3 percent) and Almaty (12.4 percent).

Such large companies as AbdiIbahim GlobalPharm, Kelun-KazPharm, Dolce, Zerde-Fito, Chimpharm, Nobel Almaty Pharmaceutical Factory, Aurora, Cheminnova Alimor Kazpharm, Rapid-Alimor Pharm Industries, Dosfarm have plants in the regions, energyprom.kz reports.

SANTO company, being a part of the international pharmaceutical group Polpharma (Poland), is implementing the largest investment project in the South Kazakhstan region to modernise the existing pharmaceutical production of Chimpharm in accordance with English Good Manufacturing Practice (GMP) international standards. The Polish investor will invest $37 million in the plant.

The main objectives of the fourth stage of the investment programme of Polpharma international group for 2018-2022 are the development of the IT infrastructure, digitisation of the production process, the improvement and automation of the quality control and quality assurance system and the development of new medicines. The company is going to build a new laboratory as well as update existing infrastructure, equipment and logistics facilities.

Over the 11 months of 2017, 14.3 percent of antibiotics sold in Kazakhstan were produced domestically. However, domestic production of other pharmaceuticals reached 53.1 percent of the total Kazakh market.
View more share chat for Tau Capital (TAU) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.